Publications and communications of Olivier Verlaine

Gholizadeh, A., Mazzucchelli, G., Verlaine, O., & Gilet, T. (15 October 2023). Flipping: A Control Strategy for Centrifugal Microfluidic Systems [Poster presentation]. Miniaturized Systems for Chemistry and Life Sciences (MicroTAS), Katowice, Poland.

Frère, J.-M., Verlaine, O., & Matagne, A. (12 September 2023). The measurement of true initial rates is not always absolutely necessary to estimate enzyme kinetic parameters. Scientific Reports, 13 (1), 15053. doi:10.1038/s41598-023-41805-y

Decuyper, L., Jukič, M., Sosič, I., Amoroso, A. M., Verlaine, O., Joris, B., Gobec, S., & D'hooghe, M. (02 January 2020). Synthesis and Penicillin-binding Protein Inhibitory Assessment of Dipeptidic 4-Phenyl-β-lactams from α-Amino Acid-derived Imines. Chemistry: An Asian Journal, 15 (1), 51-55. doi:10.1002/asia.201901470

Frère, J.-M., & Verlaine, O. (2020). First-order Kinetics in the Study of Enzymes: Applications to the Reporter Substrate Method and to the Estimation of kcat/Km. Current Biotechnology.

Decuyper, L., Magdalenić, K., Verstraete, M.-B., Jukič, M., Sosič, I., Sauvage, E., Amoroso, A. M., Verlaine, O., Joris, B., Gobec, S., & D'hooghe, M. (09 October 2019). α-Unsaturated 3-Amino-1-carboxymethyl-β-lactams as Bacterial PBP Inhibitors: Synthesis and Biochemical Assessment. Chemistry, 25 (70), 16128 - 16140. doi:10.1002/chem.201904139

De Franco, S., Vandenameele, J., Brans, A., Verlaine, O., Bendak, K., Damblon, C., Matagne, A., Segal, D., Galleni, M., Mackay, J., & Vandevenne, M. (21 February 2019). Exploring the suitability of RanBP2-type Zinc Fingers for RNA-binding protein design. Scientific Reports, 9 (1), 2484. doi:10.1038/s41598-019-38655-y

Decuyper, L., Deketelaere, S., Vanparys, L., Jukič, M., Sosič, I., Sauvage, E., Amoroso, A. M., Verlaine, O., Joris, B., Gobec, S., & D'hooghe, M. (12 October 2018). In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-β-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria. Chemistry, 24 (57), 15254-15266. doi:10.1002/chem.201801868

Lara, Y., Durieu, B., Cornet, L., Verlaine, O., Rippka, R., Stelmach Pessi, I., Misztak, A., Joris, B., Javaux, E., Baurain, D., & Wilmotte, A. (2017). Draft genome sequence of the axenic strain Phormidesmis priestleyi ULC007, a cyanobacterium isolated from Lake Bruehwiler (Larsemann Hills, Antarctica). Genome Announcements, 01546-16. doi:10.1128/genomeA.01546-16

Di Gregorio, S., Fernandez, S., Cuirolo, A., Verlaine, O., Amoroso, A. M., Mengin-Lecreulx, D., Famiglietti, A., Joris, B., & Mollerach, M. (January 2017). Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain. Microbial Drug Resistance: Mechanism, Epidemiology, and Disease, 23 (1), 44-50. doi:10.1089/mdr.2016.0160

Lara, Y., Verlaine, O., Kleinteich, J., Stelmach Pessi, I., Rippka, R., Renard, M., Cornet, L., Baurain, D., & Wilmotte, A. (03 August 2015). Genome sequencing of an endemic filamentous Antarctic cyanobacterium [Poster presentation]. 15th International Symposium on Phototrophic Prokaryotes, Tubingen, Germany.

Henry, X., Verlaine, O., Amoroso, A. M., Coyette, J., & Joris, B. (December 2013). Activity of ceftaroline against Enterococcus faecium PBP5. Antimicrobial Agents and Chemotherapy, 57 (12), 6358. doi:10.1128/AAC.00923-13

Sliwa, A., Dive, G., Zervosen, A., Verlaine, O., Sauvage, E., & Marchand-Brynaert, J. (2012). Unprecedented inhibition of resistant penicillin binding proteins by bis-2-oxoazetidinyl macrocycles. MedChemComm, 3, 344-351. doi:10.1039/c2md00251e

Turk, S., Verlaine, O., Gerards, T., Zivec, M., Humljan, J., Sosic, I., Amoroso, A. M., Zervosen, A., Luxen, A., Joris, B., & Gobec, S. (2011). New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria. PLoS ONE, 6 (5), 19418. doi:10.1371/journal.pone.0019418